# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
All of the securities to be sold in the offering are to be offered by Tonix. The Company intends to use the net proceeds from t...
Tonix Pharmaceuticals shares are trading lower by 11.3% during Monday's session. The company announced receipt of the forma...
Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10...
Tonix Pharmaceuticals secures a potential $34 million agreement with the Defense Threat Reduction Agency to develop antiviral a...